Details werden geladen...
Moderna’s experimental mRNA cancer treatment progresses, shares spike - National | Globalnews.ca
Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine designed to be tailored to individual patients based on unique mutations within their tumors.
Ähnliche Seiten
Moderna shares climb over 110% as mRNA vaccine with Merck succeeds in large trial for skin cancer | Stock Market News
https://www.livemint.com/market/stock-market-news/moderna-shares-climb-nearly-100-as-mrna-vaccine-with-merck-succeeds-in-large-trial-for-skin-cancer-11787143887774.html
Moderna cancer vaccine trial: Shares jump 177% after melanoma breakthrough - India Today
https://www.indiatoday.in/business/companies/story/moderna-cancer-vaccine-trial-shares-jump-177-after-melanoma-breakthrough-2975432-2026-08-20
FDA approves Moderna’s mRNA-based vaccine for the flu - National | Globalnews.ca
https://globalnews.ca/news/12011426/fda-moderna-mrna-based-vaccine-flu/How Moderna’s personalised mRNA cancer vaccine trains the body to hunt down tumours - India Today
https://www.indiatoday.in/science/story/how-modernas-personalised-mrna-cancer-vaccine-trains-the-body-to-hunt-down-tumours-2975533-2026-08-20
mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology | Hindustan Times
https://www.hindustantimes.com/ht-explainers/merck-moderna-melanoma-trial-mrna-cancer-vaccine-future-of-oncology-treatments-keytruda-immunotherapy-what-it-means-101787192516449.html